Haixing Zhu
-
- IL-33, ST2, and ILC Pathways 2
-
- MicroRNA in disease regulation 3
-
- Gastric Cancer Management and Outcomes 3
- Metastasis and carcinoma case studies 2
- Ferroptosis and cancer prognosis 2
-
- Asthma and respiratory diseases 3
-
- RNA modifications and cancer 3
-
- Cancer Immunotherapy and Biomarkers 2
In The Last Decade
Haixing Zhu
18 papers receiving 358 citations
Peers
Comparison fields: 5 of 79
- Immunology 115
- Immunology and Allergy 24
- Cancer Research 57
- Pulmonary and Respiratory Medicine 104
- Physiology 82
Countries citing papers authored by Haixing Zhu
This map shows the geographic impact of Haixing Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haixing Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haixing Zhu more than expected).
Fields of papers citing papers by Haixing Zhu
This network shows the impact of papers produced by Haixing Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haixing Zhu. The network helps show where Haixing Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haixing Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 11 | |
| 3 | 2022 | 28 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 19 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 15 | |
| 8 | 2021 | 50 | |
| 9 | 2021 | 21 | |
| 10 | 2021 | 8 | |
| 11 | 2019 | 27 | |
| 12 | 2019 | 3 | |
| 13 | 2019 | 8 | |
| 14 | 2017 | 24 | |
| 15 | 2014 | 2 | |
| 16 | 2013 | 15 | |
| 17 | 2013 | 3 | |
| 18 | Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. | 2011 | 122 |
| 19 | The prevalence of blood Th17 and CD4+ CD25+ Treg cells in patients with bronchial asthma. | 2010 | 2 |
About Haixing Zhu
Haixing Zhu is a scholar working on Modeling and Simulation, Pulmonary and Respiratory Medicine and Cancer Research, having authored 19 papers that have together received 367 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Asthma and respiratory diseases (3 papers), Gastric Cancer Management and Outcomes (3 papers), Metastasis and carcinoma case studies (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Immunology (115 citations), Immunology and Allergy (24 citations) and Cancer Research (57 citations). Haixing Zhu has collaborated with scholars based in China and Oman. Frequent co-authors include Hai Zhu, Yuheng Shi, Xiaoyan Jin, Huanying Wan, Guochao Shi, Gang Wang, Lihua Jiang, Wei Tang, Xinyang He and Aman Xu. Their work appears in journals such as Frontiers in Immunology, Surgery and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.